Roberts Jackson, the industrial disease specialist law firm, has received a £15m investment from NorthEdge Capital, a private equity house.
The investment from NorthEdge Capital, which focuses on investing in businesses in the North of England, is expected to help open up new opportunities in the legal services sector for the firm.
Nick Townend will join the board as finance director, while Paul Hewitt comes in as chairman, alongside founders Karen Jackson, CEO, and Oliver Jackson, strategy director.
Gladys Swaim-Rutter and Lorna Vanderkamp have been promoted to directors as part of the deal and are equity shareholders.
“The investment from NorthEdge will allow us to accelerate the growth of the business, capitalise on new opportunities within the market and hopefully provide many more clients with the very best advice," said Karen Jackson.
“Ultimately as lawyers we are here to serve our clients to the best of our ability and this investment will enable us to build upon our existing platform within the legal services sector. This is a firm that focuses on its employees and clients and we chose NorthEdge because they hold that similar belief – they invest in people just like we do and are committed to supporting the firm in many different ways going forward.”
Jon Pickering, director at NorthEdge Capital, said that he had no doubts that Roberts Jackson would further increase its market share and continue to deliver unmatched specialist expertise.
Founded in 2009, the law firm has grown from two to more than 200 people in just five years.